NOVO-NORDISK AS B DK 0,1 revenue breakdown overview

NOVO-NORDISK AS B DK 0,1 revenue for the last year amounted to 38.82 B EUR, the most of which — 36.33 B EUR — came from its highest performing source at the moment, Diabetes and Obesity Care, the year earlier bringing 28.85 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought NOVO-NORDISK AS B DK 0,1 22.38 B EUR, and the year before that — 17.10 B EUR.